Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Chan

Showing results (301-310 of 449) with videos related to

Pageof 45
Sort By:
The New England Journal of Medicine|July 13, 2012
Potassium channel KIR4.1 as an immune target in multiple sclerosisRajneesh Srivastava, Muhammad Aslam, Sudhakar Reddy Kalluri, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 29, 2025
Extracellular Vesicle Marker Changes Associated With Disease Activity in Relapsing-Remitting Multiple SclerosisVictoria Lim Falk, Nicole Mueller-Wirth, Dimitris Karathanasis, et al.
JMIR Formative Research|February 17, 2023
Development of an Open-source and Lightweight Sensor Recording Software System for Conducting Biomedical Research: Technical ReportMichael Single, Lena C Bruhin, Narayan Schütz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancerEdwin P Hui, Fion L Sung, Brian K H Yu, et al.
Multiple Sclerosis and Related Disorders|July 31, 2018
The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?Laura Barin, Anke Salmen, Giulio Disanto, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 19, 2018
Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in SwitzerlandMarco Kaufmann, Jens Kuhle, Milo A Puhan, et al.
CNS Neuroscience & Therapeutics|November 10, 2018
Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional studyAndrei Miclea, Anke Salmen, Greta Zoehner, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 29, 2010
Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington diseaseLarissa Arning, Aiden Haghikia, Elahe Taherzadeh-Fard, et al.
The New Zealand Medical Journal|February 25, 2016
Equitable care for those with rheumatic heart diseaseNigel Wilson, Rachel Webb, John Malcom, et al.
European Journal of Neurology|October 24, 2024
Treating to target in multiple sclerosis: Do we know how to measure whether we hit it?Gabriel Bsteh, Nik Krajnc, Patrick Altmann, et al.
Pageof 45

Showing results (301-310 of 449) with videos related to

Sort By:
Pageof 45
The New England Journal of Medicine|July 13, 2012
Potassium channel KIR4.1 as an immune target in multiple sclerosisRajneesh Srivastava, Muhammad Aslam, Sudhakar Reddy Kalluri, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 29, 2025
Extracellular Vesicle Marker Changes Associated With Disease Activity in Relapsing-Remitting Multiple SclerosisVictoria Lim Falk, Nicole Mueller-Wirth, Dimitris Karathanasis, et al.
JMIR Formative Research|February 17, 2023
Development of an Open-source and Lightweight Sensor Recording Software System for Conducting Biomedical Research: Technical ReportMichael Single, Lena C Bruhin, Narayan Schütz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancerEdwin P Hui, Fion L Sung, Brian K H Yu, et al.
Multiple Sclerosis and Related Disorders|July 31, 2018
The disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?Laura Barin, Anke Salmen, Giulio Disanto, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 19, 2018
Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in SwitzerlandMarco Kaufmann, Jens Kuhle, Milo A Puhan, et al.
CNS Neuroscience & Therapeutics|November 10, 2018
Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional studyAndrei Miclea, Anke Salmen, Greta Zoehner, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 29, 2010
Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington diseaseLarissa Arning, Aiden Haghikia, Elahe Taherzadeh-Fard, et al.
The New Zealand Medical Journal|February 25, 2016
Equitable care for those with rheumatic heart diseaseNigel Wilson, Rachel Webb, John Malcom, et al.
European Journal of Neurology|October 24, 2024
Treating to target in multiple sclerosis: Do we know how to measure whether we hit it?Gabriel Bsteh, Nik Krajnc, Patrick Altmann, et al.
Pageof 45